Johnson Johnson

Can GE and J&J Help Detect Alzheimer's Earlier?

Medical imaging and diagnostics powerhouse GE Healthcare teams up with pharmaceutical giant Johnson & Johnson to research methods of detecting Alzheimer's in patients -- even before they begin to exhibit symptoms of the devastating disease.

Was Johnson & Johnson aware of problems with its Children's Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this and other questions surrounding the massive recall of children's medicines earlier this year.

Johnson & Johnson Fights Charges of Recalls and Kickbacks

Johnson & Johnson shares are rebounding as the drugmaker tries to recover from a rough week, when the Justice Department charged it with paying kickbacks to a pharmacy company to boost sales of its drugs to nursing-home patients, and the Food and Drug Administration accused it of being too slow with its product recall during a Tylenol scare.

Good Results for Celgene's Cancer Drug

Drug maker Celgene (CELG) says its multiple myeloma cancer pill reduced the risk of progression by half among newly diagnosed patients who used the drug and chemotherapy compared with those who only used chemotherapy.